BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25497556)

  • 1. Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Qi WX; Fu S; Zhang Q; Guo XM
    Radiother Oncol; 2015 Mar; 114(3):289-95. PubMed ID: 25497556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis.
    Patel SH; Wang Z; Wong WW; Murad MH; Buckey CR; Mohammed K; Alahdab F; Altayar O; Nabhan M; Schild SE; Foote RL
    Lancet Oncol; 2014 Aug; 15(9):1027-38. PubMed ID: 24980873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Rim CH; Kim HJ; Seong J
    Radiother Oncol; 2019 Feb; 131():135-144. PubMed ID: 30773180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
    Sanford NN; Pursley J; Noe B; Yeap BY; Goyal L; Clark JW; Allen JN; Blaszkowsky LS; Ryan DP; Ferrone CR; Tanabe KK; Qadan M; Crane CH; Koay EJ; Eyler C; DeLaney TF; Zhu AX; Wo JY; Grassberger C; Hong TS
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):64-72. PubMed ID: 30684667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of charged particle therapy in treatment of hepatocellular carcinoma (Regarding Qi W.X. et al. charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: A systematic review and meta-analysis).
    Yamazaki H; Nakamura S; Suzuki G; Aibe N; Yoshida K
    Radiother Oncol; 2016 Feb; 118(2):420. PubMed ID: 26597232
    [No Abstract]   [Full Text] [Related]  

  • 6. Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis.
    Cheng JY; Liu CM; Wang YM; Hsu HC; Huang EY; Huang TT; Lee CH; Hung SP; Huang BS
    Radiat Oncol; 2020 Jun; 15(1):159. PubMed ID: 32605627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient specific outcomes of charged particle therapy for hepatocellular carcinoma - A systematic review and quantitative analysis.
    Spychalski P; Kobiela J; Antoszewska M; Błażyńska-Spychalska A; Jereczek-Fossa BA; Høyer M
    Radiother Oncol; 2019 Mar; 132():127-134. PubMed ID: 30825961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of publications on charged particle therapy for hepatocellular carcinoma.
    Igaki H; Mizumoto M; Okumura T; Hasegawa K; Kokudo N; Sakurai H
    Int J Clin Oncol; 2018 Jun; 23(3):423-433. PubMed ID: 28871342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.
    Que J; Kuo HT; Lin LC; Lin KL; Lin CH; Lin YW; Yang CC
    BMC Cancer; 2016 Jul; 16():451. PubMed ID: 27405814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of External Beam Radiation Therapy Modalities for Hepatocellular Carcinoma With Macrovascular Invasion: A Meta-Analysis and Systematic Review.
    Wu G; Huang G; Huang J; Lu L; Peng S; Li Y; Zhao W
    Front Oncol; 2022; 12():829708. PubMed ID: 35242713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons.
    Ramaekers BL; Pijls-Johannesma M; Joore MA; van den Ende P; Langendijk JA; Lambin P; Kessels AG; Grutters JP
    Cancer Treat Rev; 2011 May; 37(3):185-201. PubMed ID: 20817407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma.
    Abe T; Saitoh J; Kobayashi D; Shibuya K; Koyama Y; Shimada H; Shirai K; Ohno T; Nakano T
    Radiat Oncol; 2015 Sep; 10():187. PubMed ID: 26377092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment of coiled fiducial markers as internal surrogates for hepatocellular carcinomas during gated stereotactic body radiotherapy with a real-time tumor-tracking system.
    Hanazawa H; Takahashi S; Shiinoki T; Park SC; Yuasa Y; Koike M; Kawamura S; Shibuya K
    Radiother Oncol; 2017 Apr; 123(1):43-48. PubMed ID: 28285839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.
    Guarneri A; Franco P; Trino E; Campion D; Faletti R; Mirabella S; Gaia S; Ragona R; Diotallevi M; Saracco G; Salizzoni M; Ricardi U; Carucci P
    Med Oncol; 2016 Oct; 33(10):104. PubMed ID: 27566310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis.
    Grutters JP; Kessels AG; Pijls-Johannesma M; De Ruysscher D; Joore MA; Lambin P
    Radiother Oncol; 2010 Apr; 95(1):32-40. PubMed ID: 19733410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.
    Gkika E; Bettinger D; Krafft L; Schultheiss M; Neeff HP; Maruschke L; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
    Strahlenther Onkol; 2018 May; 194(5):403-413. PubMed ID: 29322205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma.
    Yamashita H; Onishi H; Murakami N; Matsumoto Y; Matsuo Y; Nomiya T; Nakagawa K;
    J Radiat Res; 2015 May; 56(3):561-7. PubMed ID: 25691453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy for hepatocellular carcinoma: Experience from a tertiary cancer care center in India.
    Madhavan R; Kunher B; Arunlal M; Nair HM; Unnikrishnan UG; Holla R; Makuny D
    Indian J Cancer; 2017; 54(1):316-320. PubMed ID: 29199713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.